Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03240588 · ClinicalTrials.gov registry record · NA
NAVITAS and ENVISION - Study to Characterize Select Objective Metrics & Clinical Outcomes in Chronic Pain Patients With Boston Scientific Neurostimulation Systems
A NA study, sponsored by Boston Scientific Corporation.
- Completed
- Registry status
- NA
- Development phase
- 544
- Enrollment target
NCT03240588 is a NA study that has completed, run by Boston Scientific Corporation. The registered enrollment target is 544 participants.
The verdict
NCT03240588, a NA study, has completed, sponsored by Boston Scientific Corporation.
- COMPLETED
- Registry status
- NA
- Development phase
- 544 participants
- Enrollment target
Study Summary
The objective of the study is to characterize the relationship between select objective metrics and clinical outcomes in chronic pain patients treated with Boston Scientific commercially approved neurostimulation systems.
Interventions
- DEVICE Neurostimulation System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 544 participants |
| Start Date | 2017-07-31 |
| Est. Completion | 2024-03-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03240588
The ClinicalTrials.gov registry entry for NCT03240588 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 544 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Neurostimulation System is the first listed.
NCT03240588 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03240588 about?
NCT03240588 is a clinical study titled "NAVITAS and ENVISION - Study to Characterize Select Objective Metrics & Clinical Outcomes in Chronic Pain Patients With Boston Scientific Neurostimulation Systems". The objective of the study is to characterize the relationship between select objective metrics and clinical outcomes in chronic pain patients treated with Boston Scientific commercially approved neurostimulation systems.
What is the current status of trial NCT03240588?
This trial is currently completed. It is a NA study. The enrollment target is 544 participants. The study started on 2017-07-31. Estimated completion is 2024-03-08.
What interventions are being tested in trial NCT03240588?
The interventions under investigation include: Neurostimulation System (DEVICE).
Who is sponsoring clinical trial NCT03240588?
This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.